NRIX
Nurix Therapeutics Inc
Price:  
20.27 
USD
Volume:  
739,206.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NRIX WACC - Weighted Average Cost of Capital

The WACC of Nurix Therapeutics Inc (NRIX) is 7.4%.

The Cost of Equity of Nurix Therapeutics Inc (NRIX) is 9.80%.
The Cost of Debt of Nurix Therapeutics Inc (NRIX) is 5.00%.

Range Selected
Cost of equity 8.30% - 11.30% 9.80%
Tax rate 0.10% - 0.50% 0.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 8.2% 7.4%
WACC

NRIX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.95 1.16
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 11.30%
Tax rate 0.10% 0.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 8.2%
Selected WACC 7.4%